Elucent Medical, Inc. Risk Report

📜 Innovation & R&D

Elucent Medical, Inc. is actively engaged in multiple innovative projects aimed at enhancing medical procedures related to breast cancer localization and surgery. The company has been recognized for their advancements in creating technology that may transform oncologic surgery practices. Their efforts in research and development are evident through their successful funding rounds and introduction of new technologies.

• Elucent Medical received FDA breakthrough device status for its surgical navigation system on 🗓 May 15, 2025, marking a significant milestone in their innovation efforts.
• The company secured Series C funding on 🗓 April 10, 2024, to propel their technological advancements in oncologic surgery.
• They raised $42.5 million on 🗓 April 16, 2024, specifically to develop cancer-surgery navigation technology.
• UW–Madison professors, in collaboration with the company, created a revolutionary GPS device for surgeons, highlighted on 🗓 January 20, 2020.